Antisense strategies for the treatment of hematological malignancies and solid tumors
β Scribed by R. Kronenwett; R. Haas
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 698 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
sister (20 x 10 6 CD34 cells/kg). As acute graft versus host disease prophylaxis she received cyclosporin A (1,5 mg/kg from day -1). From day +16 we observed aGVHD ,,0 in the skin and gastrointestinal tract. Administration of metylprednisolon in max. dose of 1,5 mg/kg proved effecttive. No toxicity
## Abstract Anemia is common in patients with hematological malignancy. Most patients will have their anemia attributed to the anemia of chronic disease. The anemia of chronic disease is caused by cytokine mediated suppression of erythropoiesis and low serum erythropoietin levels are found in the m
There is now a substantial body of evidence that tumor growth is angiogenesisdependent, and that neovascularization is also necessary for tumor invasion and metastasis. In addition, the assessment of microvessel count or density in a primary tumor may ultimately prove to be a significant and indepen